Market Insights
Market Research Future has revealed key market figures for the global Buergers disease market in its report on the subject. Projected to growth at a CAGR of 3.1% during the forecast period of 2017 to 2023, the global Buerger's disease market is expected to grow to reach an approximate value of USD 383 Mn by the end of the assessment period. The disease is rare and highly severe as it affects the blood vessels in the arms and legs thus leading to serious complications such as gangrene and other infections.
Request Sample Copy:
https://www.marketresearchfuture.com/sample_request/4015
At present, there is no suitable treatment path for the diseases and the market is primarily driven by research and the demand for the same. The diseases have received increased media coverage and have spread awareness after it was found that the Filipino President is afflicted with Buerger's disease. Although the precise cause of the disease is not clear, excessive use of tobacco has been found to be responsible to a certain extent. Increased investment in research and ongoing development of new therapies combined with launches of clinical trials are expected to drive market growth. Moreover, many companies are seeking approval for new treatments. In 2016, Stempeutics Research Pvt Ltd received partial approval for a stem cell-based treatment option of Buerger's disease. Growing advancements in medical technology and a rapidly developing global healthcare sector will lead to crucial discoveries and increase the availability of effective treatment for Buerger's disease.
Market Segmentation
The global Buerger's disease market is segmented on the basis of diagnosis, treatment, and end-user. By diagnosis, the market is segmented into tissue biopsy, Allen's test, angiograms, and others. The angiogram segment is sub-segmented to include Computerized Tomography (CT) scan, Magnetic Resonance Imaging (MRI) scans, X-Rays, and others.
By treatment, the market is segmented into smoking cessation and other treatments. Other treatments include intermittent compression of arms & legs, spinal cord stimulation, medication, surgery, amputation, therapeutic angiogenesis, and others. Other sub-segmentations are recorded in the report.
By end-user, the market is segmented into hospitals & clinics, academic institutes, medical research centers, and others.
Regional Analysis
The Americas hold the largest share of the global market due to the inclusion of the region of North America, which is a largely developed region. The U.S has been recorded as the highest revenue generating market in North America. The region has availability of funds for intensive research and clinical trials. While advanced diagnostic and treatment options are readily adopted, and market players work actively to produce the same. Latin America is growing significantly due to the presence of emerging economies with a high demand for advanced healthcare, particularly in countries such as Argentina, Chile, and Brazil.
Europe is the second largest market in the global Buerger's disease market due to the increasing incidences found in the region. Western Europe with its inclusion of Germany, U.K, and France dominate the market. Meanwhile, the Asia Pacific is poised to gro
w at the highest CAGR during the forecast period. Increasing awareness of Buerger's disease, increased investments in research and a focus on improving the regions healthcare sector are important factors governing the growth of the market in the APAC region. China and India are the major countries in the market and government support for the expansion of the market are likely to produce various opportunities in the future.
Key Players
The competitive landscape for the global Buerger's disease market is made up of prominent players such as Koninklijke Philips N.V., t2cure GmbH, Siemens Healthcare GmbH, STEMPEUTICS RESEARCH PVT LTD, Pluristem, Toshiba Medical Corporation, FUJIFILM Holdings Corporation, Shimadzu Corporation, General Electric Company, and others. MRFR has recorded these players' market strategies and positions for the careful analysis of the market in total.
Browse Complete Report with TOC at
https://www.marketresearchfuture.com/reports/buergers-disease-market-4015
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
Buerger’s Disease Market information, by diagnosis (blood tests, The Allen's test, angiogram, and others), by treatment (smoking cessation, other treatments, and others), by end user- global forecast till 2027Market HighlightsThe global Buerger’s disease market has been evaluated as a steady market and it is expected to continue growing in the near future.
Introduction and increasing adoption of advanced diagnostic tools and new therapies are another important factor for the market growth.The market for Buerger’s disease was around USD 309.3 million in 2016 and is expected to reach USD 383.0 million by 2023 which is a projected CAGR of 3.1%.Taste the market data and market information presented through more than 52 market data tables and figures spread over 82 pages of the project report.
Avail the in-depth table of content TOC & market synopsis on “Buerger’s Disease Market Research Report–Global Forecast to 2023.”Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4015Major players in Buerger’s disease market:There are plenty of large and small market players which operate in this market: FUJIFILM Holdings Corporation (Japan), General Electric Company (US), Koninklijke Philips N.V. (Netherlands), pluristem (Israel), Shimadzu Corporation (Japan), Siemens Healthcare GmbH (Germany), STEMPEUTICS RESEARCH PVT LTD (India) Toshiba Medical Corporation (Japan), t2cure GmbH (Germany), and others.Regional Analysis:Considering the global scenario of the Buerger’s disease market, there are four main regions, America, Europe, Asia Pacific, and Middle East & Africa.America is the largest market for Buerger’s disease.
The Americas mainly include North America and Latin America.
Some major factors like advanced diagnostic and treatment facilities, funding for research, clinical trials and new drugs and therapy development, and rapid adoption of new therapies, are the driving forces for the growth for North America Buerger’s disease market.
Talking about the market scenario of Middle East & Africa, this region is expected to grow significantly during the forecast period due to various factors such as increasing number of smokers, and changing healthcare practices.
